CARE
125.60 SAR
+3.00%
Today
+3.41%
1D
Last seen at Thu, 05 Mar 2026 14:43:00 GMT+3
Market is closed
Sun
9:00 AM ~ 2:00 PM
Mon
9:00 AM ~ 2:00 PM
Tue
9:00 AM ~ 2:00 PM
Wed
9:00 AM ~ 2:00 PM
Thu
9:00 AM ~ 2:00 PM
Fri
Closed
Sat
Closed
Performance
1 Day
+ 3.41 %
1 Week
- 5.34 %
1 Month
- 26.00 %
3 Month
- 17.02 %
6 Month
- 32.87 %
1 Year
- 27.78 %
Information
Name
National Medical Care JSC
Currency
SAR
Standard Leverage
1X
Market Cap
6.40B
Avg Daily Volume
85.72K
52 Week High
183.5 SAR
52 Week Low
132.5 SAR
Trading Hours
See hours
Business Summary
National Medical Care Company establishes, owns, equips, manages, maintains, and operates healthcare facilities in the Kingdom of Saudi Arabia. The company operates Care Medical Rawabi; Care Medical Malaz; Care Company for Pharmaceutical and Medical Distribution; and Braya Al-Taifi Center for Rehabilitation. It also provides home healthcare services. The company was founded in 2003 and is based in Riyadh, the Kingdom of Saudi Arabia.
Top News
MOBI.OTC
-1.42%
Suncor
+0.58%
CanadianNatRes
+2.58%
Imperial Oil stock hit with another downgrade as high-flying shares spook analysts
finance.yahoo.com
1w ago
MOBI.OTC
-1.42%
Suncor
+0.58%
CanadianNatRes
+2.58%
Imperial Oil cut to 'underperform'; RBC sees stock 'disconnected from its fundamentals'
finance.yahoo.com
1w ago
Enbridge
-0.48%
Enbridge: Canadian oil a 'meat and potato' staple for U.S. Gulf refineries
finance.yahoo.com
2w ago
Frequently Asked Questions
What are healthcare stocks and why are they important to investors?
Healthcare stocks include pharmaceutical companies, biotech firms, hospitals, and medical device manufacturers.
Are healthcare stocks less volatile?
Generally yes. Because healthcare is a necessity, demand remains relatively steady, making the sector less sensitive to economic cycles.
What drives growth in healthcare investments?
Aging populations, technological advancements, and increased healthcare spending contribute to long-term growth in the sector.
What are the risks of investing in healthcare?
Regulatory changes, drug approval delays, and legal challenges can affect the profitability and stock prices of healthcare companies.
